Samlyn Capital »

Dyne Therapeutics shares owned by Samlyn Capital

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Samlyn Capital from 13F filings

Historical chart of Samlyn Capital investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Samlyn Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Samlyn Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $29M 1.5M 19.56

More positions owned by Samlyn Capital

Lpl Financial Holdings (LPLA)
Bank of America Corporation (BAC)
Capital One Financial (COF)
Microsoft Corporation (MSFT)
Morgan Stanley Com New (MS)
First Solar (FSLR)
JPMorgan Chase & Co. (JPM)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Core & Main Cl A (CNM)
NVIDIA Corporation (NVDA)
Rb Global (RBA)
Spotify Technology S A SHS (SPOT)
Meta Platforms Cl A (META)
MercadoLibre (MELI)
Asml Holding N V N Y Registry Shs (ASML)

View all positions for Samlyn Capital

Top funds holding Dyne Therapeutics

T. Rowe Price Investment Management
Vanguard Group
BlackRock
Atlas Venture Life Science Advisors
State Street Corporation
FMR
Fcpm Iii Services B.v.
Adage Capital Partners GP
Orbis Allan Gray
TCG Crossover Management
Siren
Perceptive Advisors
Geode Capital Management
Frazier Life Sciences Management
Deep Track Capital

View all funds holding Dyne Therapeutics